Dysregulations of the JAK-STAT signal pathway, the NF-κB signaling pathway or the Notch signal pathway were reported to be extensively involved in the development of pancreatic cancer, among which pathways some signaling molecules have become promising potential therapeutic targets for PC therapy [3,4,5,6]. Here, NFKB1 is linked to pancreatic neoplasm.